These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9634925)

  • 81. The treatment of Sjögren's disease in NZB/NZW F1 hybrid mice with azathioprine: a two-stage study.
    Yeoman CM; Franklin CD
    Clin Exp Rheumatol; 1994; 12(1):49-53. PubMed ID: 8162642
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cytokine mRNA expression in labial salivary glands and cytokine secretion in parotid saliva in Sjögren's syndrome.
    Fox PC; Grisius MM; Bermudez DK; Sun D
    Adv Exp Med Biol; 1998; 438():909-15. PubMed ID: 9634987
    [No Abstract]   [Full Text] [Related]  

  • 83. Identification of cells infiltrating the minor salivary glands in patients with Sjögren's syndrome.
    Chused TM; Hardin JA; Frank MM; Green I
    J Immunol; 1974 Feb; 112(2):641-8. PubMed ID: 4544361
    [No Abstract]   [Full Text] [Related]  

  • 84. Sjögren's syndrome: studying the disease in mice.
    Delaleu N; Nguyen CQ; Peck AB; Jonsson R
    Arthritis Res Ther; 2011 Jun; 13(3):217. PubMed ID: 21672284
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Age-related decrease in innervation density of the lacrimal gland in mouse models of Sjögren's syndrome.
    Walcott B; Claros N; Patel A; Brink PR
    Adv Exp Med Biol; 1998; 438():917-23. PubMed ID: 9634988
    [No Abstract]   [Full Text] [Related]  

  • 86. Sjögren syndrome: advances in the pathogenesis from animal models.
    Chiorini JA; Cihakova D; Ouellette CE; Caturegli P
    J Autoimmun; 2009; 33(3-4):190-6. PubMed ID: 19800762
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Gene cloning of BM180, a lacrimal gland enriched basement membrane protein with a role in stimulated secretion.
    Asrani AC; Lumsden AJ; Kumar R; Laurie GW
    Adv Exp Med Biol; 1998; 438():49-54. PubMed ID: 9634862
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The cornea in keratoconjunctivitis sicca.
    Pflugfelder SC; Stern ME
    Exp Eye Res; 2020 Dec; 201():108295. PubMed ID: 33038387
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Neurological and Inflammatory Manifestations in Sjögren's Syndrome: The Role of the Kynurenine Metabolic Pathway.
    de Oliveira FR; Fantucci MZ; Adriano L; Valim V; Cunha TM; Louzada-Junior P; Rocha EM
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544839
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanisms.
    Brandt JE; Priori R; Valesini G; Fairweather D
    Biol Sex Differ; 2015; 6():19. PubMed ID: 26535108
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Potentially pathogenic immune cells and networks in apparently healthy lacrimal glands.
    Mircheff AK; Wang Y; Ding C; Warren DW; Schechter JE
    Ocul Surf; 2015 Jan; 13(1):47-81. PubMed ID: 25557346
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease.
    Mostafa S; Seamon V; Azzarolo AM
    Exp Eye Res; 2012 Mar; 96(1):88-97. PubMed ID: 22227485
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MUC1/A and MUC1/B splice variants differentially regulate inflammatory cytokine expression.
    Imbert-Fernandez Y; Radde BN; Teng Y; Young WW; Hu C; Klinge CM
    Exp Eye Res; 2011 Nov; 93(5):649-57. PubMed ID: 21854773
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Autoimmunity at the ocular surface: pathogenesis and regulation.
    Stern ME; Schaumburg CS; Dana R; Calonge M; Niederkorn JY; Pflugfelder SC
    Mucosal Immunol; 2010 Sep; 3(5):425-42. PubMed ID: 20485329
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of inflammation on lacrimal gland function.
    Zoukhri D
    Exp Eye Res; 2006 May; 82(5):885-98. PubMed ID: 16309672
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats.
    Alves M; Calegari VC; Cunha DA; Saad MJ; Velloso LA; Rocha EM
    Diabetologia; 2005 Dec; 48(12):2675-81. PubMed ID: 16283249
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjögren's syndrome.
    Rocha EM; Wickham LA; Huang Z; Toda I; Gao J; da Silveira LA; Sullivan DA
    Adv Exp Med Biol; 1998; 438():485-91. PubMed ID: 9634925
    [No Abstract]   [Full Text] [Related]  

  • 98. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome.
    Sato EH; Sullivan DA
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2632-42. PubMed ID: 8163351
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Influence of androgen therapy on lacrimal autoimmune disease in a mouse model of Sjögren's syndrome.
    Sullivan DA; Rocha FJ; Sato EH
    Adv Exp Med Biol; 1995; 371B():1199-202. PubMed ID: 7502783
    [No Abstract]   [Full Text] [Related]  

  • 100. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
    Johnson BC; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.